General, these results show that ketamine need to be considered a pharmacologic selection for chronic neuropathic pain refractory to standard treatment. More studies are needed to figure out the ideal treatment dosages and frequencies To maximise the benefits of ketamine whilst minimizing its side effects. The best evidence for efficacy https://charlesz333yod2.blogsmine.com/profile